XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Unaudited Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Revenues $ 23,881 $ 26,799 $ 74,241 $ 80,126
Cost of revenues 23,364 23,227 69,533 69,925
Gross margin 517 3,572 4,708 10,201
Operating expenses:        
Research and development 2,083 2,657 7,076 8,368
Selling, general and administrative 7,173 6,777 22,084 20,615
Amortization of acquisition-related intangibles 690 628 2,058 1,840
Change in fair value of contingent consideration (220) (2,110) (340) (4,440)
Total operating expenses 9,726 7,952 30,878 26,383
Operating loss (9,209) (4,380) (26,170) (16,182)
Interest income, net 42 12 112 68
China dissolution 0 0 (1,921) 0
Other income (expense), net (287) 45 (48) 7
Loss before income tax expense (9,454) (4,323) (28,027) (16,107)
Income tax expense (benefit) 127 1 144 (1,946)
Net loss $ (9,581) $ (4,324) $ (28,171) $ (14,161)
Net loss per common share        
Basic (in dollars per share) $ (0.34) $ (0.16) $ (1.01) $ (0.52)
Diluted (in dollars per share) $ (0.34) $ (0.16) $ (1.01) $ (0.52)
Weighted average number of common shares outstanding        
Basic (in shares) 27,954 27,352 27,794 27,145
Diluted (in shares) 27,954 27,352 27,794 27,145